Z
Zora Modrusan
Researcher at Genentech
Publications - 230
Citations - 31152
Zora Modrusan is an academic researcher from Genentech. The author has contributed to research in topics: Cancer & Gene. The author has an hindex of 72, co-authored 208 publications receiving 25114 citations.
Papers
More filters
Journal ArticleDOI
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
Heidi S. Phillips,Samir Kharbanda,Ruihuan Chen,William F. Forrest,Robert Soriano,Thomas D. Wu,Anjan Misra,Janice Nigro,Howard Colman,Liliana Soroceanu,P. Mickey Williams,Zora Modrusan,Burt G. Feuerstein,Kenneth Aldape +13 more
TL;DR: Previously undescribed prognostic subclasses of high-grade astrocytoma are identified and discovered to resemble stages in neurogenesis, suggesting functional relevance of tumor subtype molecular signatures is suggested by the ability of cell line signatures to predict neurosphere growth.
Journal ArticleDOI
Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens
Yan Zheng,Patricia Valdez,Dimitry M. Danilenko,Yan Hu,Susan M Sa,Qian Gong,Alexander R. Abbas,Zora Modrusan,Nico Ghilardi,Frederic J. de Sauvage,Wenjun Ouyang +10 more
TL;DR: This work shows that interleukin-22 (IL-22) has a crucial role in the early phase of host defense against C. rodentium and identifies a new innate immune function for IL-22 in regulating early defense mechanisms against A/E bacterial pathogens.
Journal ArticleDOI
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
Mahesh Yadav,Suchit Jhunjhunwala,Qui T. Phung,Patrick J. Lupardus,Joshua Tanguay,Stephanie M. Bumbaca,Christian Franci,Tommy K. Cheung,Jens Fritsche,Toni Weinschenk,Zora Modrusan,Ira Mellman,Jennie R. Lill,Lélia Delamarre +13 more
TL;DR: An approach that combines whole-exome and transcriptome sequencing analysis with mass spectrometry to identify neo-epitopes in two widely used murine tumour models indicates that a suitable prediction algorithm may provide an approach for the pharmacodynamic monitoring of T-cell responses as well as for the development of personalized vaccines in cancer patients.
Journal ArticleDOI
Recurrent R-spondin fusions in colon cancer
Somasekar Seshagiri,Eric Stawiski,Steffen Durinck,Zora Modrusan,Elaine E. Storm,Caitlin B. Conboy,Subhra Chaudhuri,Yinghui Guan,Vasantharajan Janakiraman,Bijay S. Jaiswal,Joseph Guillory,Connie Ha,Gerrit J. P. Dijkgraaf,Jeremy Stinson,Florian Gnad,Melanie A. Huntley,Jeremiah D. Degenhardt,Peter M. Haverty,Richard Bourgon,Weiru Wang,Hartmut Koeppen,Robert Gentleman,Timothy K. Starr,Zemin Zhang,David A. Largaespada,Thomas D. Wu,Frederic J. de Sauvage +26 more
TL;DR: The R-spondin gene fusions, several new recurrent mutations in the Wnt pathway gene TCF7L2, chromatin-remodelling genes such as TET2 and TET3 and receptor tyrosine kinases including ERBB3 are identified and shown to be capable of potentiating Wnt signalling.
Journal ArticleDOI
Diverse somatic mutation patterns and pathway alterations in human cancers
Zhengyan Kan,Bijay S. Jaiswal,Jeremy Stinson,Vasantharajan Janakiraman,Deepali Bhatt,Howard M. Stern,Peng Yue,Peter M. Haverty,Richard Bourgon,Jianbiao Zheng,Martin Moorhead,Subhra Chaudhuri,Lynn P. Tomsho,Brock A. Peters,Kanan Pujara,Shaun Cordes,David Davis,Victoria Carlton,Wenlin Yuan,Li Li,Weiru Wang,Charles Eigenbrot,Joshua S. Kaminker,David A. Eberhard,Paul Waring,Stephan C. Schuster,Zora Modrusan,Zemin Zhang,David Stokoe,Frederic J. de Sauvage,Malek Faham,Somasekar Seshagiri +31 more
TL;DR: This study provides an overview of the mutational spectra across major human cancers and identifies several potential therapeutic targets.